Furthermore, increased visfatin levels were found to be associated with atherosclerotic disease and coronary artery disease, pathologies demonstrated to be among the main mortality causes in NAFLD [16,17,18,19]. Here, NAMPT is linked to metabolic dysfunction-associated steatotic liver disease.